Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matrix remodeling-associated protein 8 (MXRA8) is a type I transmembrane protein involved in cartilage formation, angiogenesis regulation, and blood-brain barrier maintenance. It also acts as an entry receptor for arthritogenic alphaviruses. In cancer, high MXRA8 expression is associated with poor prognosis in glioma and identifies a subset of cancer-associated fibroblasts (CAFs) in pancreatic ductal adenocarcinoma. Targeting MXRA8 has shown promise in inhibiting tumor cell proliferation and inducing ferroptosis.
Inhibition of MXRA8 leads to increased NCOA4 expression and decreased FTH1 levels, promoting ferroptosis. Antibody-based therapies targeting MXRA8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix remodeling-associated protein 8 (MXRA8).